Zydus Lifesciences gets FDA final approval for Balsalazide Disodium Capsules
Zydus Lifesciences, along with its subsidiaries and affiliates, has achieved a significant milestone with the final approval from the US Food and Drug Administration (FDA) for Balsalazide Disodium Capsules USP, 750 mg (known as Colazal Capsules, 750 mg in the US market). Balsalazide Disodium is a medication primarily used to treat bowel diseases such as […]